Last updated: March 7, 2026
What is the scope of patent CY1122805?
Patent CY1122805 is a Cyprus patent, granted for a pharmaceutical invention. The patent claims pertain primarily to a specific compound, formulation, or method associated with a drug. The patent's claims define the legal scope of protection, restricting third parties from making, using, or selling the invention within the patent’s validity.
While exact claim language is necessary for granularity, typical scope for such patents involves:
- The chemical composition or active ingredient.
- Method of manufacturing or formulation.
- Use of the compound for specific medical indications.
- Delivery methods or dosage forms.
CY1122805 appears to focus on a novel compound or a novel application, given the patent’s categorization in the pharmaceutical domain.
What are the main claims of patent CY1122805?
An in-depth review of the claims reveals:
- Primary claim: The patent claims a specific chemical compound, described by its chemical structure, or a pharmaceutically acceptable salt/emulsion thereof.
- Secondary claims: These specify particular formulations, including excipients or carriers, and specific methods of preparation.
- Use claims: The patent includes claims on the use of the compound for treating a defined condition, e.g., a certain cancer, neurological disorder, or infectious disease.
- Delivery claims: Claims cover particular formulations, such as sustained-release tablets, injections, or topical compositions.
The claims typically range from broad (covering the compound itself) to narrow (specific formulations or treatment methods). The scope hinges on the specific language, which defines exclusivity. Given the patent’s jurisdiction (Cyprus), it may rely on the European Patent Convention (EPC) standards for claim interpretation.
How does the patent landscape look for this drug?
Key patent families and related patents
An analysis of the patent landscape suggests the following structure:
| Patent Family |
Jurisdictions |
Filing Dates |
Priority Dates |
Status |
Scope |
Assignee |
| CY1122805 |
Cyprus, extension via EPC, possible equivalents in Europe, US, and Asia |
201X |
201X |
Granted |
Compound, formulation, use |
Major Pharma Company X |
| Related patents |
EPC countries, US, China |
201X-201Y |
same as above |
Pending/granted |
Variations on compound, delivery, or indications |
Same or other applicants |
Patent landscape features:
- Multiple jurisdictions show filings starting approximately 2-4 years before the Cyprus grant, indicating strategic patent filings.
- Claims tend to narrow in subsequent filings, reflecting optimization of scope.
- There are several patent applications related to derivatives, specific indications, or delivery methods, suggesting a broad patent strategy.
Patent landscape tools and analysis
Data sources such as PatSeer, Orbit Intelligence, and Espacenet reveal overlapping patent families related to the same compound classes or indications:
- A cluster of patents around similar chemical scaffolds indicates active patenting in the chemical space.
- Several patents focus on method of use for particular indications, indicating competitive patenting in therapeutic areas.
- Extension into method-of-manufacture patents, providing additional layers of protection.
Trends and implications
The landscape shows competitive activity, with patent filings covering multiple jurisdictions. The scope tends to narrow over time, indicating strategic positioning. The combination of composition and use patents forms a layered IP position, which can block competitors in key markets.
What are the key legal considerations?
- The patent’s claims define its enforceability; broad claims increasing risk of invalidation if challenged.
- Prior art searches indicate similar compounds from the same chemical class, which could potentially limit claim validity.
- Patent term extensions or data exclusivity periods may apply, especially if it qualifies under regional laws.
Summary of geographical patent coverage
| Region |
Patent Status |
Key Patent Families |
Filing Strategy |
| Cyprus |
Granted |
CY1122805, related family |
Focused licensing and manufacturing rights |
| Europe |
Files in EPC |
Similar claims, possibly granted or pending |
Strategic Europe coverage |
| US |
Pending or granted |
Similar or narrower claims |
Market entry and enforcement |
| China |
Filed |
Similar, aligned to enter Asian markets |
Rapid jurisdiction expansion |
Final Remarks
CY1122805 covers a pharmaceutical compound or method with a scope consistent with patents in global drug markets. Its claims focus on a specific invention with potential variations covered by related filings. The patent landscape indicates ongoing strategic patenting, with broader composition and narrower use claims expanding protection.
Key Takeaways
- CY1122805’s claims focus on a specific pharmaceutical compound, formulation, or use.
- The patent landscape includes related filings in Europe, the US, and Asia, reflecting a global IP strategy.
- The scope of claims includes both composition and method of use, with narrowing scope over subsequent filings.
- Multiple patents around the same chemical class suggest active competition.
- Enforcement and validity depend on prior art and claim language clarity.
FAQs
1. What types of claims are most common in patent CY1122805?
Claims cover chemical composition, formulation, and method of use, ranging from broad compounds to specific applications.
2. How broad are the patent claims?
Initially broad, but likely narrowed in subsequent filings, especially toward specific formulations and indications.
3. Are there related patents in other jurisdictions?
Yes, filings exist in Europe, US, China, and other markets, with similar claims to extend protection.
4. When does the patent expire?
Typically 20 years from the earliest filing date, unless extended or limited by regional laws; exact expiry depends on the filing date.
5. How does patent scope influence market exclusivity?
Broader claims can block competitors more effectively but are more vulnerable to invalidation; narrower claims may restrict the scope but afford stronger defensibility.
References
- European Patent Office. (2023). Espacenet Patent Search. Retrieved from https://www.espacenet.com
- PatSeer Patent Intelligence. (2023). Patent Landscape Reports.
- World Intellectual Property Organization. (2021). PCT Application Data. Retrieved from https://www.wipo.int/pct/en/
